Category Specific RSS

asx pxs

FDA gives green light to Pharmaxis drug trial in liver cancer where there’s a desperate need for new treatments

Clinical stage drug development company, Pharmaxis (ASX: PXS) is making a name for themselves in the oncology sector, with their…

4 years ago

Pharmaxis targeting scar-free recovery from burns with world-first trials

One of the world’s most respected surgeons in the field of burns and trauma recovery will lead world-first clinical trials…

5 years ago

Pharmaxis sales thriving in US following FDA approval for cystic fibrosis treatment

The world’s most lucrative healthcare market is quickly appreciating Aussie pharmaceuticals company Pharmaxis (ASX: PXS) whose cystic fibrosis (CF) treatment…

5 years ago